Auris Medical to Redomicile Holding Company from Switzerland to Bermuda
Move to Bermuda will enhance corporate flexibility, reduce costs and provide better alignment with U.S. corporate law Subject to […]
REPEAT – Premier Health Announces Closing of Cloud Practice Inc. Acquisition
Cloud Practice Inc., a medical software application company with products including: Juno EMR, a cloud based EMR solution; ClinicAid, a […]
FTI Consulting Expands E-Discovery Managed Services Offering to the Relativity Platform
From Self-Service to Fully Managed, Flexible Offering Provides Corporations and Law Firms with Efficient and Cost-Effective E-Discovery Solution WASHINGTON, Jan. […]
KemPharm Announces Enhancements to U.S. and Global Intellectual Property Estate
Patents Extend Across KemPharm’s Prodrug Portfolio, Including IP Protection for KP415 in Canada, Japan and Korea CELEBRATION, Fla., Jan. 29, […]
TSX News -
Alderon Appoints Financial Advisor to Arrange Transaction for the Development of the High-Grade Kami Iron Ore Project
MONTRÉAL, Jan. 29, 2019 (GLOBE NEWSWIRE) — Alderon Iron Ore Corp. (TSX: IRON) (“Alderon” or the “Company”) is pleased to […]
VR Discovers Porphyry Copper Mineral System at Its Junction Property, Nevada; Exploration Advances.
VANCOUVER, B.C., Jan. 29, 2019 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the “Company”, or […]
betterU advances its corporate training efforts in India and is awarded two contracts totalling for $26,812
OTTAWA, Ontario, Jan. 29, 2019 (GLOBE NEWSWIRE) — betterU Education Corp. (the “Company” or “betterU”) is pleased to announce the […]
OncoCyte Announces Successful Results of DetermaVu™ R&D Validation Study
Results show 90% sensitivity and 75% specificity, demonstrating best-in-class performance On track for commercial availability of DetermaVu™ Lung in 2H […]
Susie Garvin Joins MGP Beverage Alcohol Sales Team
Leads international sales ATCHISON, Kan., Jan. 29, 2019 (GLOBE NEWSWIRE) — MGP Ingredients, Inc. (Nasdaq:MGPI), a leading supplier of premium […]
TSX News -
IMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDA
DECIDE phase 2 clinical trial amendment successfully completed with multiple sites now open for enrollment FDA provided guidance for future […]
